arrow
J

Janet Dunn

university of warwick
H指数:62
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT

50岁及以上乳腺癌患者乳腺X线摄影筛查:Mammo-50随机对照试验的概要

2026-05-010
PRE
Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer

通过坚持辅助内分泌治疗改善早期乳腺癌女性的结局(SWEET):一项实用性随机对照试验的研究方案,旨在通过以患者为中心的干预措施提高早期乳腺癌患者对内分泌治疗的依从性。

2025-11-261
OAAI
FAST MRI: DYAMOND trial protocol (can an abbreviated MRI scan detect breast cancers missed by mammography for screening clients with average mammographic density attending their first screening mammogram?)-a diagnostic yield study within the NHS population-risk breast screening programme

快速MRI:DYAMOND试验方案(缩短的MRI扫描能否检测出乳腺X光筛查中遗漏的乳腺癌,用于乳腺X光密度平均水平且首次参加乳腺X光筛查的筛查对象?)——一项在NHS人群风险评估乳腺癌筛查项目中的诊断收益研究

2025-09-280
OAAI
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
2025-02-130
OA
What factors influence cellular pathologists' confidence in case reporting?
2024-08-170
OAAI
Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using an enriched dataset
2024-05-280
OAAI
Mammographic surveillance in early breast cancer patients aged 50 years or over: results of the Mammo-50 non-inferiority trial of annual versus less frequent mammography
2024-05-020
PRE
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study

用于报告组织病理学样本 (包括癌症筛查样本) 的数字病理学-来自多站点研究的确凿证据

2024-01-172
OAAI
OPTIMA, a prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in high clinical risk early breast cancer
2023-03-011
PRE
ATNEC: A multicentre, randomized trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in the axillary lymph nodes after neoadjuvant chemotherapy
2023-03-010
PRE
Evaluating the effectiveness of abbreviated breast MRI (abMRI) interpretation training for mammogram readers: a multi-centre study assessing diagnostic performance, using an enriched dataset
2022-07-303
OAAI